| |
| |
|
| Insider
Information: |
Schuchart Aaron |
| Relationship: |
Chief Business Officer |
| City: |
Austin |
| State: |
TX |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
9,179 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$21,672 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
9,179 |
|
|
| Total
Value |
$21,672 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
0
|
|
Stock
price went up :
|
2
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
2.0
|
0.0
|
| Percentage
Gain/Loss : |
 10.3%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Aeglea Biotherapeutics, Inc. |
AGLE |
Chief Business Officer |
2018-09-27 |
2,500 |
2018-08-17 |
0 |
Premium* |
|
|
Lumos Pharma Inc |
LUMO |
Chief Business Officer |
2024-04-01 |
6,679 |
2021-08-11 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
10 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LUMO |
Lumos Pharma Inc |
Chief Business Officer |
• – – |
2024-04-01 |
4 |
A |
$2.84 |
$2,840 |
D/D |
1,000 |
6,679 |
0 |
- |
|
| LUMO |
Lumos Pharma Inc |
Chief Business Officer |
• – – |
2024-02-01 |
4 |
D |
$3.01 |
$608 |
D/D |
(202) |
5,679 |
0 |
- |
|
| LUMO |
Lumos Pharma Inc |
Chief Business Officer |
• – – |
2023-02-01 |
4 |
D |
$3.52 |
$366 |
D/D |
(104) |
5,381 |
0 |
- |
|
| LUMO |
Lumos Pharma Inc |
Chief Business Officer |
• – – |
2023-02-01 |
4 |
A |
$3.52 |
$3,520 |
D/D |
1,000 |
5,485 |
0 |
- |
|
| LUMO |
Lumos Pharma Inc |
Chief Business Officer |
• – – |
2022-02-01 |
4 |
D |
$10.02 |
$521 |
D/D |
(52) |
3,985 |
0 |
- |
|
| LUMO |
Lumos Pharma Inc |
Chief Business Officer |
• – – |
2022-02-01 |
4 |
A |
$10.02 |
$10,020 |
D/D |
1,000 |
4,037 |
0 |
- |
|
| LUMO |
Lumos Pharma Inc |
Chief Business Officer |
• – – |
2021-08-12 |
4 |
B |
$7.42 |
$12,614 |
D/D |
1,700 |
3,037 |
2.74 |
% |
|
| LUMO |
Lumos Pharma Inc |
Chief Business Officer |
• – – |
2021-08-11 |
4 |
B |
$7.35 |
$2,205 |
D/D |
300 |
1,337 |
2.66 |
% |
|
| AGLE |
Aeglea Biotherapeutics, I... |
Chief Business Officer |
• – – |
2018-09-27 |
4 |
S |
$9.50 |
$57,005 |
D/D |
(6,000) |
2,500 |
0 |
- |
|
| AGLE |
Aeglea Biotherapeutics, I... |
Chief Business Officer |
• – – |
2018-08-17 |
4 |
OE |
$3.50 |
$29,750 |
D/D |
8,500 |
8,500 |
0 |
- |
|
10 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
